Page last updated: 2024-08-21

pyrazines and Respiratory Syncytial Virus Infections

pyrazines has been researched along with Respiratory Syncytial Virus Infections in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Lupfer, C; Pastey, MK; Patton, KM	1

Other Studies

1 other study(ies) available for pyrazines and Respiratory Syncytial Virus Infections

Article	Year
Treatment of human respiratory syncytial virus infected Balb/C mice with the proteasome inhibitor bortezomib (Velcade, PS-341) results in increased inflammation and mortality. Toxicology, 2010, Jan-31, Volume: 268, Issue:1-2 Topics: Animals; Antiviral Agents; Boronic Acids; Bortezomib; Chlorocebus aethiops; Cytokines; Enzyme Inhibitors; Inflammation; Mice; Mice, Inbred BALB C; Proteasome Inhibitors; Pyrazines; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Vero Cells; Virus Replication	2010

Article

Year

Treatment of human respiratory syncytial virus infected Balb/C mice with the proteasome inhibitor bortezomib (Velcade, PS-341) results in increased inflammation and mortality.

Toxicology, 2010, Jan-31, Volume: 268, Issue:1-2

Topics: Animals; Antiviral Agents; Boronic Acids; Bortezomib; Chlorocebus aethiops; Cytokines; Enzyme Inhibitors; Inflammation; Mice; Mice, Inbred BALB C; Proteasome Inhibitors; Pyrazines; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Vero Cells; Virus Replication

2010